Literature DB >> 15517512

Formulation substitution: a frequently overlooked variable in cardiovascular drug management.

James A Reiffel1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15517512     DOI： 10.1016/j.pcad.2004.04.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  3 in total

1.  Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.

Authors:  Meytal A Tsadok; Cynthia A Jackevicius; Elham Rahme; Vidal Essebag; Mark J Eisenberg; Karin H Humphries; Jack V Tu; Hassan Behlouli; Jennifer Joo; Louise Pilote
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

Review 2.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

3.  Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom.

Authors:  Hussain Mulla; Magdi Tofeig; Frances Bu'Lock; Nilesh Samani; Hitesh C Pandya
Journal:  Arch Dis Child       Date:  2007-03-15       Impact factor: 3.791
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.